| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Brennan Murray serves as a Director at TCRT. Across recent SEC filings that breaks down to 0 buys and 2 sells. Those positions are worth an estimated $145K at current prices.
The biggest single holding is TCRT (~$145K) as Director. The recent filings there lean toward selling, a net 40,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 4, 2015 | TCRT Alaunos Therapeutics, Inc. | Director | Sell | 40,000 | $9.70 | $387,807.71 | -56.5% |